(Q45731773)

15 December 2017

title

Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART. (English)

1 reference

15 December 2017

0 references

Cathal E O'Sullivan

1

1 reference

15 December 2017

RongSheng Peng

2

1 reference

15 December 2017

Kelly Stefano Cole

3

1 reference

15 December 2017

Ronald C Montelaro

4

1 reference

15 December 2017

Timothy Sturgeon

5

1 reference

15 December 2017

Hal B Jenson

6

1 reference

15 December 2017

Paul D Ling

7

1 reference

15 December 2017

publication date

1 July 2002

1 reference

Journal of Medical Virology

15 December 2017

published in

1 reference

15 December 2017

volume

67

1 reference

15 December 2017

issue

3

1 reference

15 December 2017

page(s)

320-326

1 reference

Phenotypic analysis of antigen-specific T lymphocytes

15 December 2017

cites work

1 reference

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults

21 January 2018

1 reference

Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients

21 January 2018

1 reference

Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children

21 January 2018

1 reference

The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection

21 January 2018

1 reference

Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.

21 January 2018

1 reference

The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection

21 January 2018

1 reference

Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy

21 January 2018

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

Hepatitis C viraemia in HIV-HCV co-infected patients having immune restoration with highly active antiretroviral therapy.

21 January 2018

1 reference

Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy

21 January 2018

1 reference

Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JMV.10080

1 reference

15 December 2017

1 reference